Breast cancer study halted

Jun 20, 2007

The U.S. National Cancer Institute halted a $100 million study of drugs designed to prevent breast cancer in women at risk for the disease.

The study couldn't be justified amid questions of cost, safety and overall benefit, the institute announced Tuesday.

The dangers of introducing these drugs, with their many known side effects, outweighs their potential," the institute said.

While proponents argued the study was crucial to determining the best drugs to prevent breast cancer, other advocacy groups called for more research to better identify women who would benefit most.

The study would have tested a new generation of drugs known as aromatase inhibitors, The Washington Post reported Wednesday. Under the study, about 12,800 women in the United States and Canada would have received raloxifene or the aromatase inhibitor letrozole.

About 180,000 American women are diagnosed with breast cancer each year and about 40,000 die from the disease, making breast cancer the second most common cancer in women.

Copyright 2007 by United Press International

Explore further: Spicy treatment the answer to aggressive cancer?

Related Stories

Report details benefits of investment in basic research

Apr 27, 2015

Last year was a notable one for scientific achievements: In 2014, European researchers discovered a fundamental new particle that sheds light on the origins of the universe, and the European Space Agency ...

Device extracts rare tumor cells using sound

Apr 06, 2015

A simple blood test may one day replace invasive biopsies thanks to a new device that uses sound waves to separate blood-borne cancer cells from white blood cells.

Recommended for you

Spicy treatment the answer to aggressive cancer?

Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.